Publiserte artikler fra Spesialregister for lungekreft

Rostad H, Naalsund A, Norstein J, Jacobsen R, Aalokken TM. Er behandlingen av lungekreft i Norge god nok? Tidsskr Nor Laegeforen. 2002 Sep 30;122(23):2258-62. Norwegian.

Berstad AE, Kolbenstvedt A, Aalokken TM, Naalsund A, Rostad H. Computertomografi ved lungekreft - teknikk og kvalitet. Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3384-6. Norwegian.

Rostad H, Naalsund A, Jacobsen R, Strand TE, Norstein J. Årsaker til mortalitet etter reseksjon for lungekreft. Tidsskr Nor Laegeforen. 2004 Feb 5;124(3):313-5. Norwegian.

Strand TE, Malayeri C, Eskonsipo PK, Grimsrud TK, Norstein J, Grotmol T. Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954-1998. Cancer Causes Control. 2004 Feb;15(1):27-33.

Rostad H, Naalsund A, Jacobsen R, Eirik Strand T, Scott H, Heyerdahl Strom E, Norstein J. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy? Eur J Cardiothorac Surg. 2004 Oct;26(4):782-6.

Rostad H, Naalsund A, Strand TE, Jacobsen R, Talleraas O, Norstein J. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years. Eur J Cardiothorac Surg. 2005 Feb;27(2):325-8.

Strand TE, Malayeri C, Eskonsipo PK, Grimsrud TK, Norstein J, Grotmol T. Tenåringsrøyking og lungekreft i tidlig voksen alder, 1954 - 98. Tidsskr Nor Laegeforen. 2005 May 4;125(9):1174-6. Norwegian.

Strand TE, Rostad H, Moller B, Norstein J. Survival after resection for primary lung cancer: a population-based material of 3,211 resected patients. Thorax. 2006 Apr 6.

Rostad H, Strand TE, Naalsund A, Talleraas O, Norstein J. Lung cancer surgery: the first 60 days. A population-based study. Eur J Cardiothorac Surg. 2006 May; 29(5):824-8. Epub 2006 Mar 7.

Strand TE, Rostad H, Damhuis RAM, Norstein J. Risk factors for 30‐day mortality after resection of lung cancer and prediction of their magnitude. Thorax. 2007;62:991-7

Rostad H, Strand TE, Naalsund A, Norstein J. Resected synchronous primary malignant lung tumors: a population-based study. Ann Thorac Surg. 2008;85:204‐9.

Strand TE. Editorial: More emphazise on resection rates! J Thorac Oncol. 2012;7:1067-8

Rostad H, Strand TE, Langmark FY, Naalsund A. [Lung cancer without metastases‐‐are all patients with resectable tumor operated?]. Tidsskr Nor Laegeforen. 2008;128:920‐3.

von Plessen C, Strand TE, Wentzel‐Larsen T, Omenaas E, Wilking N, Sundstrøm S, Sörenson S. Effectiveness of third‐generation chemotherapy on the survival of patients with advanced non‐small cell lung cancer ‐ a national study. Thorax. 2008;63:866-71.

Strand TE. Rostad H, Wentzel-Larsen T, Von Plessen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J. 2010;36:401-7

Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Klint Å, Peake M, Strand TE, Linklater K, Robinson D, Møller H.National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax. 2010;65:436- 41.

Strand TE, Brunsvig PF, Johannessen DC, Sundstrøm S, Wang M, Hornslien K, Bremnes RM, Stensvold A, Garpestad O, Norstein J. Potentially curative radiotherapy for non-small cell lung cancer in Norway – a population-based study of survival. Int J Radiat Oncol Biol Phys. 2011;80:133-41. Epub 2010 May 6.

Naalsund A, Rostad H, Strøm EH, Lund MB, Strand TE. Carcinoid lung tumors - incidence, treatment and outcomes: a population-based study. Eur J Cardiothorac Surg. 2011;39:565-9.

 Strand TE, Bartnes K, Rostad H. National trends in lung cancer surgery. Eur J Cardiothorac Surg. 2012;42:355-8